Drug: insulin Quarter: 2016Q3
Total Records: 528 Number of Pages: 27
DRUGNAME | PT | EventCount |
---|---|---|
INSULIN | Wrong technique in product usage process | 2 |
INSULIN ASPART | Autonomic nervous system imbalance | 2 |
INSULIN ASPART | Autonomic neuropathy | 2 |
INSULIN ASPART | Electrocardiogram QT prolonged | 2 |
INSULIN ASPART | Foetal exposure during pregnancy | 2 |
INSULIN ASPART | Hypoglycaemia neonatal | 2 |
INSULIN ASPART | Sinus tachycardia | 2 |
INSULIN ASPART | Ventricular extrasystoles | 2 |
INSULIN DEGLUDEC | Acute kidney injury | 2 |
INSULIN DEGLUDEC | Blood glucose increased | 2 |
INSULIN DEGLUDEC | Cardiac failure congestive | 2 |
INSULIN DEGLUDEC | Haemodialysis | 2 |
INSULIN DEGLUDEC | Rhabdomyolysis | 2 |
INSULIN DEGLUDEC | Toxicity to various agents | 2 |
INSULIN DETEMIR | Blood glucose decreased | 2 |
INSULIN DETEMIR | Hypoglycaemia neonatal | 2 |
INSULIN DETEMIR | Loss of consciousness | 2 |
INSULIN GLARGINE | Acute kidney injury | 2 |
INSULIN GLARGINE | Apraxia | 2 |
INSULIN GLARGINE | Asthenia | 2 |
Total Records: 528 Number of Pages: 27